ESRX - Express Scripts Holding Company
95.00 +0.06 (0.06%)
Pre-Market: 8:13AM EDT
| Previous Close | 95.23 |
| Open | 94.95 |
| Bid | 94.50 x 3100 |
| Ask | 95.00 x 1200 |
| Day's Range | 94.28 - 96.04 |
| 52 Week Range | 55.80 - 96.45 |
| Volume | 10,576,156 |
| Avg. Volume | 4,073,453 |
| Market Cap | 53.368B |
| Beta | 1.20 |
| PE Ratio (TTM) | 11.56 |
| EPS (TTM) | 8.21 |
| Earnings Date | Oct 22, 2018 - Oct 26, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2003-11-12 |
| 1y Target Est | 87.70 |
- Yahoo Finance Contributors•3 days ago
5 Trade Ideas for Monday: Anthem, Express Scripts, Edwards Lifesciences, Graco & Raytheon
GuruFocus.com•20 hours agoDepartment of Justice Approves Cigna-Express Scripts Deal
Clearing a major hurdle in the health care space's path to consolidation, Cigna Corp. (CI) announced on Monday its $52 billion acquisition of Express Scripts Holding Co. (ESRX) was approved by the U.S. Department of Justice, sending shares higher in after-hours trading. Warning! GuruFocus has detected 3 Warning Signs with AVGO. By combining the Bloomfield, Connecticut-based health insurer and the St. Louis-based pharmacy benefits manager, Tim Wentworth, president and CEO of Express Scripts, said the companies hope to "transform" health care by reducing costs, expanding choice and improving patient outcomes.
- Zacks•22 hours ago
Cigna Moves Closer to Express Scripts Buyout With DoJ Nod
Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.
Markit•yesterdaySee what the IHS Markit Score report has to say about Express Scripts Holding Co.
Express Scripts Holding Co NASDAQ/NGS:ESRX
- The Wall Street Journal•yesterday
[$$] Stocks to Watch: FedEx, Oracle, Avon, Express Scripts
The market reacts to quarterly results from FedEx and Oracle, as well as a takeover overture for Avon.
- Reuters•yesterday
PRESS DIGEST -Wall Street Journal - Sept 18
The following are the top stories in the Wall Street Journal. - Apple Inc dodged stinging duties on its smartwatches and wireless earbuds after the U.S. excluded those gadgets from tariffs on $200 billion in Chinese goods, though the tech giant still faces retaliatory measures being weighed by China that could strike iPhone production there. - SpaceX's first paying passenger will be Japanese billionaire Yusaku Maezawa, who is to blast off from earth in 2023, circle the moon and return, the company's founder and chief executive, Elon Musk, said at an event Monday evening.
Reuters•2 days agoCigna deal gets antitrust nod, positive sign for CVS/Aetna
The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.
Reuters•2 days agoCigna deal gets antitrust nod, positive sign for CVS/Aetna
The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.
Reuters•2 days agoCigna deal gets antitrust nod, positive sign for CVS-Aetna
The decision bodes well for the pending U.S. antitrust review of CVS Health Corp's (CVS.N) proposed $69 billion acquisition of health insurer Aetna Inc (AET.N). The new company will marry Cigna's business of managing health plans for corporations and the government with Express Scripts' (ESRX.O) role handling pharmacy benefits for those same customers.
- Bloomberg•2 days ago
Congratulations, Cigna! Now Comes the Hard Part.
Cigna Corp. has successfully dodged two giant obstacles in its attempt to purchase pharmacy-benefit manager Express Scripts Holding Co. First, it got past Carl Icahn, who tried to convince investors to vote no on the deal in August, only to drop the effort days later after giving it further thought.
- Bloomberg•2 days ago
Cigna-Express Scripts Deal Is Cleared by U.S. Justice Department
Antitrust enforcers signed off on Cigna Corp.’s $54 billion takeover of pharmacy-benefit manager Express Scripts Holding Co., clearing one of two health-care deals that stand to reshape the industry. Approval by the Justice Department smooths the way for the deal to wrap up by the end of the year, the companies said Monday in a joint statement. Express Scripts shares rose 3.7 percent to $95.23 at the close in New York.
- CNBC•2 days ago
DOJ clears Cigna's acquisition of Express Scripts
The U.S. Department of Justice has cleared Cigna's acquisition of Express Scripts, the companies announced in a statement Monday. Shareholders voted to approve the merger last month, despite opposition from activist investor Carl Icahn. The U.S. Department of Justice has cleared Cigna CI 's $52 billion acquisition of Express Scripts ESRX , the companies announced in a statement Monday.
- PR Newswire•7 days ago
Express Scripts Implements Emergency Procedures for Affected Members in Advance of Hurricane Florence
ST. LOUIS, Sept. 12, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Florence, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies. In accordance with State of Emergency declarations in South Carolina, North Carolina, Virginia, Maryland, and the District of Columbia, Express Scripts (ESRX) has implemented emergency procedures for its members in these areas, including Medicare, Medicaid and TRICARE® beneficiaries, and patients who fill medications via the company's Accredo specialty pharmacy.
Motley Fool•9 days agoWhy Express Scripts Gained 11% in August
Second-quarter results were strong enough to lift the company's sales outlook last month.
- Moody's•13 days ago
Express Scripts Holding Company -- Moody's changes direction of Express Scripts rating review from uncertain to downgrade
Moody's Investors Service ("Moody's") changed the direction of its rating review of the senior unsecured debt of Express Scripts Holding Company ("Express Scripts") from review direction uncertain to review for downgrade. Moody's placed Express Scripts' Baa2 senior unsecured ratings under review with direction uncertain on March 9, 2018 following the announcement that Cigna Corporation ("Cigna") reached a definitive agreement to acquire Express Scripts in a transaction valued at approximately $67 billion.
- Investor's Business Daily•13 days ago
IBD Stock Of The Day: This Health Leader Hits Buy Point After Tight Trading
Anthem stock is surging from buy zone after several weeks of tight trading. As IBD founder William J. O'Neil mused, constructive patterns often have periods of tight trading.
- American City Business Journals•13 days ago
WellCare in talks to buy some CVS-Aetna assets, Wall Street Journal reports
The report comes on the heels of the Tampa managed health care provider wrapping up the largest deal in its history.
- Bloomberg•13 days ago
Cigna Is Selling Bonds to Finance Express Scripts Deal
Cigna Corp. sold $20 billion of bonds to fund its takeover of Express Scripts Holding Co., making for the U.S. corporate-bond market’s second-biggest of the year. The health insurer issued senior unsecured bonds in 10 parts, according to a person with knowledge of the matter. The longest portion of the offering, a $3 billion security maturing in 2048, yields 1.87 percentage points above Treasuries, after initially discussing around 2.05 percentage points, said the person, who asked not to be identified because talks with potential investors are private.
- The Wall Street Journal•14 days ago
[$$] Justice Department Nearing Antitrust Approval of Health Mergers Combining CVS-Aetna, Cigna-Express Scripts
WASHINGTON—Justice Department antitrust enforcers are preparing to give the green light to two deals in the health-care industry, CVS Health Corp.’s planned acquisition of health insurer Aetna Inc. and Cigna Corp.’s planned purchase of Express Scripts Holding Co., according to people familiar with the matter. Both deals could receive formal antitrust approval as soon as the next few weeks, these people said. The Justice Department has identified some competition concerns surrounding the nearly $70 billion CVS-Aetna deal, and the companies will be required to sell off assets related to Medicare drug coverage to resolve those issues, some of the people familiar with the matter said.
- Bloomberg•14 days ago
Major Health-Industry Deals Move Closer to Approval
The U.S. Department of Justice is on track to soon approve the acquisition of pharmacy-benefit manager Express Scripts Holding Co. by health insurer Cigna Corp., as well as CVS Health Corp.’s takeover of insurer Aetna Inc., said the person, who asked not to be identified because the process is private. CVS and Aetna are in talks with the Justice Department about divesting Medicare prescription drug plans to resolve the government’s concerns the deal will otherwise harm competition. “We continue to constructively work with the Department of Justice and remain confident the deal will close by the end of the year,” said Brian Henry, a spokesman for Express Scripts.
- CNBC•14 days ago
Justice Department reportedly close to approving CVS-Aetna, Cigna-Express Scripts deals
The Department of Justice is close to approving CVS Health's acquisition of Aetna and Cigna's acquisition of Express Scripts, The Wall Street Journal reported Wednesday, citing people familiar with the matter.
- PR Newswire•14 days ago
Inside Rx® Prescription Savings Card Boosts Deep Discounts on Brand-Name Medications to more than 130 Drugs
FRANKLIN LAKES, N.J., Sept. 5, 2018 /PRNewswire/ -- Inside Rx, LLC, a partially owned subsidiary of Express Scripts (ESRX), today announced it added 14 new medications to its brand medications listing for the Inside Rx® prescription savings card. The program now offers deep discounts to over 130 brand-name drugs to patients who are uninsured or underinsured and pay the retail price for their medications.
GuruFocus.com•19 days ago5 Stocks With Low Price-Sales Ratios
According to the GuruFocus All-in-One Screener, the following stocks with market caps over $5 billion look cheap since they are trading with low price-sales ratios. Warning! GuruFocus has detected 7 Warning Signs with BTI. British American Tobacco PLC (BTI) is trading around $49 per share with a price-sales ratio of 3.86 and a price-earnings ratio of 2.10.
- Zacks•19 days ago
Express Scripts (ESRX) Up 13.2% Since Last Earnings Report: Can It Continue?
Express Scripts (ESRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- The Wall Street Journal•26 days ago
[$$] Shareholders Approve Cigna-Express Scripts Deal
Cigna Corp. and Express Scripts Holding Co. shareholders overwhelmingly supported Cigna’s $54 billion purchase of the pharmacy-benefit manager, a deal that activist investor Carl Icahn initially sought to block. The deal received the backing of about 90% of Cigna shareholders, the health insurer said Friday, citing a preliminary vote tally. Of the Express Scripts shareholders who voted Friday, 99% approved the deal.
